Vivos Inc. Leads the Charge in Veterinary Cancer Care Innovation
Vivos Inc. (OTCQB: RDGL) proudly reports the remarkable progress achieved by its IsoPet Animal Cancer Division in veterinary cancer treatment. With a renewed dedication to improving animal health, Vivos has expanded its certified veterinary clinic network across the United States, aiming for higher accessibility and quality outcomes.
A Year of Significant Milestones for IsoPet
Major Developments in 2024
The year 2024 marked significant growth for IsoPet, a key player in minimally invasive animal cancer therapies. The division successfully launched various initiatives aimed at innovating and expanding veterinary cancer care, further solidifying its role in this vital field.
Dedicated Division Launch
In response to the increasing demand for specialized veterinary care, IsoPet was established as a dedicated division within Vivos Inc. This strategic move highlighted the company's commitment to enhancing veterinary cancer treatments while positioning the division for expansive growth under the leadership of a skilled team.
Awareness Through Marketing Campaigns
Nationwide outreach efforts in veterinary communities have proven pivotal. A newly launched website offers resources for both pet owners and veterinary professionals, providing support and information about IsoPet's solutions. The marketing campaign aims to elevate public awareness regarding innovative approaches to treating animal cancer.
Expanding Access: Certified Clinics on the Rise
Increasing Number of Certified Veterinary Clinics
The number of clinics certified to use IsoPet's treatments increased significantly in 2024, reflecting the growing popularity and acceptance of these innovative therapies. With ambitions to continue this upward trend, future expansions are in sight as additional clinics undergo certification.
Robust Engagement with Veterinary Professionals
IsoPet's active engagement with the veterinary community has resulted in a streamlined clinic certification process and new initiatives aimed at facilitating the training of veterinary staff. The introduction of a certification fee has only enhanced the robust pipeline of clinics eager to adopt IsoPet practices.
Innovation Drives Future Success
Social Media and Conference Activities
IsoPet has significantly expanded its digital presence, utilizing social media platforms to interact positively with pet owners and veterinary experts alike. Participation in major veterinary conferences has showcased the advantages of IsoPet's methodologies for treating a diverse range of animal species.
Notable Achievements in Animal Treatment
This past year not only saw the successful treatment of various common pets but also remarkable firsts, such as applying IsoPet therapy in exotic animals. Noteworthy cases, including the treatment of a ferret and managing heel pain in horses, have set the stage for broader applications of this treatment modality.
A Bright Future for Veterinary Oncology
Market Potential and Strategic Vision
The global veterinary oncology sector presents an enormous opportunity, projected to grow significantly in the coming years. With many millions of pets diagnosed with cancer annually, IsoPet is strategically positioned to meet this escalating demand through advanced and efficient treatment options.
Looking Ahead: Goals for 2025
IsoPet aims to continue growth into 2025, with plans to add even more certified clinics, enhance collaboration with leading veterinary hospitals, and implement practices to streamline treatment procedures. By doing so, it hopes to make innovative cancer therapies increasingly accessible and affordable for caregivers and pet owners alike.
A Message from the CEO
Michael Korenko, President & CEO of Vivos Inc., expressed enthusiasm about the strides made, stating, “Our focus has been on enhancing our marketing strategies effectively. Our goal is to expand our reach while ensuring more pets receive the benefits of IsoPet's groundbreaking treatments. The reception from clinics and pet owners has been overwhelmingly positive.”
About IsoPet Division
IsoPet specializes in targeted radioactive therapies designed specifically for animals. Their approach not only emphasizes safety but also aims to optimize the quality of life for pets undergoing treatment. It reflects a growing recognition of the need for established, effective veterinary cancer care methodologies.
Frequently Asked Questions
What is Vivos Inc.'s main focus with IsoPet?
Vivos Inc. is dedicated to advancing veterinary cancer care through innovative treatments and expanding their network of certified clinics.
How many clinics are certified to use IsoPet treatments?
As of 2024, there are 13 clinics certified to provide IsoPet treatments, with plans for further expansion.
What types of animals can benefit from IsoPet therapy?
IsoPet therapy is applicable to a variety of animals, including small pets, equines, exotic pets, and zoo animals.
What impact has IsoPet had in the veterinary community?
IsoPet has raised awareness about animal cancer treatments and facilitated easy access for veterinary professionals through education and certification programs.
What are the growth prospects for IsoPet in the coming years?
The veterinary oncology market is growing rapidly, and IsoPet's innovative treatments are positioned to meet the increasing demand for effective cancer therapies.
